Menu
Log in
  • PO Box 450 Mawson ACT, 2607 Australia

  • 02 6260 4022

Technical Alert: GMP approach for overseas manufacturers of medicines and biologicals during COVID-19

06 Jul 2020 10:17 AM | Anonymous member (Administrator)

The TGA have announced new arrangements to allow continued and flexible oversight of licenced domestic manufacturers by performing remote GMP inspections for some overseas manufacturers from July 2020, following the suspension of overseas GMP inspections and QMS audits due to COVID-19 travel restrictions. Click here for more information.

Copyright © 2019 Complementary Medicines Australia. All rights reserved.

Powered by Wild Apricot Membership Software